The following data is part of a premarket notification filed by Biowave Corporation with the FDA for Biowavego.
Device ID | K180943 |
510k Number | K180943 |
Device Name: | BioWaveGO |
Classification | Stimulator, Nerve, Transcutaneous, For Pain Relief |
Applicant | Biowave Corporation 8 Knight Street, Suite 201 Norwalk, CT 06851 |
Contact | Bradford Siff |
Correspondent | Dave Mcgurl Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) 1050 K Street NW, Suite 1000 Washington, DC 20001 |
Product Code | GZJ |
CFR Regulation Number | 882.5890 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2018-04-10 |
Decision Date | 2018-08-17 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00859911006010 | K180943 | 000 |
00859911006140 | K180943 | 000 |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BIOWAVEGO 88350504 not registered Live/Pending |
BioWave Corporation 2019-03-21 |